Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

Response Biomedical (RBM.TO)

BUY
Led by one of the most reputable and solid management teams in healthcare. In food agnostics right now and has the right partners. Diversified with 2 products, a hospital cardiac diagnostic tool.
BUY
Does medical testing which is a big, big market. Have all the approvals they need and just need to sell a few more testers. Likes the long-term potential, so picks away at it. Good management team.
WEAK BUY
Tecnhnology soundds attractive, but work has to be done yet.
WAIT
Has some potential.
Showing 1 to 4 of 4 entries
  • «
  • 1
  • »

Response Biomedical (RBM.TO) Frequently Asked Questions

What is Response Biomedical stock symbol?

Response Biomedical is a OTC stock, trading under the symbol RBM.TO (previously RBM-T on Stockchase) on the undefined (undefined). It is usually referred to as or RBM.TO

Is Response Biomedical a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on RBM.TO (previously RBM-T on Stockchase) on Stockchase. Read the latest expert commentary for Response Biomedical.

Is Response Biomedical a good investment or a top pick?

Response Biomedical was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Response Biomedical.

Why is Response Biomedical stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Response Biomedical.

Is Response Biomedical worth watching?

Response Biomedical is covered by Stockchase experts and is worth watching.